Download Free Medical The Impact of COVID-19 on Cancer Treatment in Spain PowerPoint Presentation

The Impact of COVID-19 on Cancer Treatment in Spain PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : This report titled, “The Impact of COVID-19 on Cancer Treatment in Spain” is by the IQVIA Institute and is a voluntary, unpaid, IQVIA-sponsored survey of Oncologists, Hem-oncologists and Onco-surgeons examining the impact of coronavirus COVID-19 on cancer treatment in Spain.

Tags : Healthcare, Oncology, cancer, Cancer Treatment, COVID-19, Spain, Oncologists, Hem-oncologists, Onco-surgeons

Published on : Jul 20, 2020 | Views : 1803 | Downloads : 0

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

© 2020. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and various other countries. Spain Report Impact of COVID-19 on cancer treatment
Slide 2-

1 Overview What is the purpose of this report? The purpose of this report is to determine if there has been any changes reported in the treatment of cancer across Spain now as restrictions ease and exit lockdown We will be comparing what Onco Specialists are telling us now (Wave 2) vs what they said at the start of the pandemic (Wave 1) The information gathered from IQVIA’s Onco Specialists community provides insight and understanding into key topics such as: The impact of cancer patient visits at different phases during COVID -19 Interaction via telehealth/ remote consultations during difference phases of the pandemic What specific type of treatment practices are impacted? What are the current changes anticipated now that restrictions are being relaxed? What pharma/biotech initiatives can help Onco Specialists deliver the best care possible their patients What communication channels are pharma companies using to communicate with Onco Specialists? How and When was the data collected? Onco Specialists were invited to participate via email and the survey was hosted on DocNet – IQVIA’s internal and secure online community for healthcare professionals This survey was not sponsored by any IQVIA client/customer. IQVIA was not compensated in any way for this survey Data collection occured from the 17th of June – 22nd of June 2020 (Wave 2) We will be comparing results with our Wave 1 survey that took place between 2nd of April – 6th of April 2020 (Wave 1) Impact of COVID-19 on cancer treatment – Spain June 2020. Copyright 2020 IQVIA. All rights reserved.
Slide 3-

2 Across Spain, 123 physicians voluntarily participated in a 3 mins survey that IQVIA hosted on DOCNET 39% Hematologist 9% Hem-Oncologist 51% Oncologists 1% Radiotherapists Wave 2 (n=123) Sample split Q0. Which of the following best describes your primary medical specialty? Impact of COVID-19 on cancer treatment – Spain June 2020. Copyright 2020 IQVIA. All rights reserved.
Slide 4-

3 There has been a rise in the number of cancer patients seen per week as restrictions ease in Spain but is still significantly lower than pre COVID days Average* number of cancer patients seen prior to COVID-19 outbreak Average number of cancer patients seen per week (Wave 1) Average number of cancer patients seen last week (Wave 2) 82 Patients 41 Patients 54 Patients Pandemic Outburst Exiting Lockdown Q1: After the COVID-19 outbreak, are you seeing fewer hematology/oncology patients per week? Wave 2 (n=58) Wave 1 (n=52) Impact on number of cancer patient seen due to COVID 19 outbreak Impact of COVID-19 on cancer treatment – Spain June 2020. Copyright 2020 IQVIA. All rights reserved. * Weighted average of Wave 1 and Wave 2 Note: All numbers shown in slide are absolute numbers (number of patients)
Slide 5-

4 Restrictions led to a huge spike in remote consultations (6% to 59%), however with time, Onco Specialists believe this would become a part of their practice 6% Prior to COVID outbreak 59% During lockdown 37% Post lockdown 21% When COVID won’t exist Q2: Could you please estimate the typical proportion of interaction via telehealth/remote consultation in the following time period? % proportion of patients on remote consultations Impact of COVID-19 on cancer treatment – Spain June 2020. Copyright 2020 IQVIA. All rights reserved.
Slide 6-

5 59% 55% Lesser biopsy/ diagnosis A slight level of improvement was observed vs wave 1 on delay in surgeries, lesser biopsies and delayed chemotherapy Wave 1 Wave 2 Delay in surgeries 71% 61% 70% 46% Delayed chemotherapy Q3: What according to you is the impact on cancer treatment practice amidst the COVID-19 crisis? Wave 2 (n=123) Wave 1 (n=59) Impact of COVID 19 crisis on cancer treatment Impact of COVID-19 on cancer treatment – Spain June 2020. Copyright 2020 IQVIA. All rights reserved.
Slide 7-

6 13% Patients Physicians Hospitals Increased remote consultations, limited visitor policies and change in treatment protocol to include orals/SC therapies are some of the key practice changes seen by Onco Specialists Change in treatment protocol to introduce oral cancer medications Change treatments to include cancer medications which patients can self- administer Addition of more surgery days/ chemo cycles Increased daily working hours Increased frequency of remote consultations Refer patients to other facilities due to lack of hospital infrastructure Allow in-person visits primarily for critical and/or newly diagnosed cancer patients 42% 25% 25% 32% 88% Limited visitor policy except in case of end of life circumstances 66% 53% Q4: What key changes are you currently seeing in your practice setting as we see restrictions being relaxed to some extent now? Impact of COVID-19 on cancer treatment – Spain June 2020. Copyright 2020 IQVIA. All rights reserved.
Slide 8-

7 To maintain social distancing, E-mails, webinars and virtual meetings have become current new modes to connect with Onco Specialists Current modes of communication Physicians’ expectations from pharma companies Q5: What initiatives can pharma/biotech take in order to help you manage increased cancer patients in the coming few months? Q6: In the current COVID-19 scenario, which of the following communication channels are pharma companies using to communicate with you? To increase patient support services 79% 64% Update on the availability of critical oncology drugs for their patients Tips on how to best communicate remotely with the rest of their practice and patients 62% Availability of an online resource center which can be accessed for product related information 58% E-mail 88% Webinars 82% Virtual Meetings 74% Messaging app 59% Phone Call 59% Post / Direct Mail 7% Face to face 2% No Contacts NA Impact of COVID-19 on cancer treatment – Spain June 2020. Copyright 2020 IQVIA. All rights reserved.
Slide 9-

8 DISCLAIMER Sample size is not representative at country level. Sample composition varies at the country level. Sample sizes are different between Wave 1 and Wave 2 – Its important to keep that in mind when making comparisons between the changes observed in responses. In addition, some Oncology specialists might be responding to questions based on what they have actually experienced, whilst others may be based on what they believe might happen. This was a pulse survey. The questions asked are intended to provide top level insight into what Oncology specialists across the country are experiencing. Impact of COVID-19 on cancer treatment – Spain June 2020. Copyright 2020 IQVIA. All rights reserved.
Slide 10-

© 2020. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and various other countries. For further information, please contact: GlobalPI@IQVIA.com

User Presentation
Related Presentations

The Beginning of Human Life and Prevention of Chronic Disease: Reframing the First 1,000 Days

By: docshare
Views: 2825

Market shifts and digital revolution in Healthcare

By: docshare
Views: 1985

Advancing Glycemic Management in People with Diabetes

By: docshare
Views: 1538

Longevity is the Next Disruption in the Field of Wellness

By: docshare
Views: 1918

Understanding the Global Landscape of Genomic Initiatives

By: docshare
Views: 1730

Familial Cancer Risk Assessment: Breast and Ovarian Cancer

By: JenniferDwayne
Views: 1452

CBD Stones Stricture Carcinoma Gall Bladder Cholangiocarcinoma

By: drdwayn
Views: 1538

Genetic and Hereditary Factors in Reproductive Cancers

By: VineetaBose
Views: 545

Neoplasia II - Invasion Metastasis and Effects of Tumours

By: JenniferDwayne
Views: 2387

Non-Hodgkins Lymphoma

By: drdwayn
Views: 2198

docshare

About : I am a passionate medical marketing professional with hands on experience in healthcare digital marketing.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : India
Website :

HEALTH A TO Z